Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 50

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The Mechanism of Inhibition of Antibody-based Inhibitors of Membrane-type Serine Protease 1 (MT-SP1)

Farady, Christopher J., Sun, Jeonghoon, Darragh, Molly R., Miller, Susan M., Craik, Charles S. · 2007 · Journal of Molecular Biology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jmb.2007.03.078

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 43

  1. Rawlings, 2006, MEROPS: the peptidase database, Nucl. Acids Res., 34, D270, 10.1093/nar/gkj089 · DOI · Paper page
  2. Laskowski, 1980, Protein inhibitors of proteinases, Annu. Rev. Biochem., 49, 593, 10.1146/annurev.bi.49.070180.003113 · DOI · Paper page
  3. Eggers, 2001, The role of ecotin dimerization in protease inhibition, J. Mol. Biol., 308, 975, 10.1006/jmbi.2001.4754 · DOI
  4. Tyndall, 2005, Proteases universally recognize beta strands in their active sites, Chem. Rev., 105, 973, 10.1021/cr040669e · DOI · Paper page
  5. Rydel, 1991, Refined structure of the hirudin-thrombin complex, J. Mol. Biol., 221, 583, 10.1016/0022-2836(91)80074-5 · DOI · Paper page
  6. Castro, 1996, Alanine point-mutations in the reactive region of bovine pancreatic trypsin inhibitor: effects on the kinetics and thermodynamics of binding to beta-trypsin and alpha-chymotrypsin, Biochemistry, 35, 11435, 10.1021/bi960515w · DOI
  7. Coussens, 2002, Matrix metalloproteinase inhibitors and cancer: trials and tribulations, Science, 295, 2387, 10.1126/science.1067100 · DOI · Paper page
  8. Dennis, 2000, Peptide exosite inhibitors of factor VIIa as anticoagulants, Nature, 404, 465, 10.1038/35006574 · DOI · Paper page
  9. Roberge, 2001, A novel exosite on coagulation factor VIIa and its molecular interactions with a new class of peptide inhibitors, Biochemistry, 40, 9522, 10.1021/bi010592d · doi:10.1021/bi010592d
  10. Krook, 1997, Selection of a cyclic nonapeptide inhibitor to alpha-chymotrypsin using a phage display peptide library, Mol. Divers., 3, 149, 10.1023/A:1009697515328 · DOI
  11. Hansen, 2005, A urokinase-type plasminogen activator-inhibiting cyclic peptide with an unusual P2 residue and an extended protease binding surface demonstrates new modalities for enzyme inhibition, J. Biol. Chem., 280, 38424, 10.1074/jbc.M505933200 · DOI
  12. Wang, 1995, Isolation of a high affinity inhibitor of urokinase-type plasminogen activator by phage display of ecotin, J. Biol. Chem., 270, 12250, 10.1074/jbc.270.20.12250 · DOI
  13. Dennis, 1994, Kunitz domain inhibitors of tissue factor-factor VIIa. II. Potent and specific inhibitors by competitive phage selection, J. Biol. Chem., 269, 22137, 10.1016/S0021-9258(17)31766-0 · doi:10.1016/s0021-9258(17)31766-0
  14. Stoop, 2003, Engineering of a macromolecular scaffold to develop specific protease inhibitors, Nature Biotechnol., 21, 1063, 10.1038/nbt860 · DOI
  15. Rezacova, 2001, Structural basis of HIV-1 and HIV-2 protease inhibition by a monoclonal antibody, Structure, 9, 887, 10.1016/S0969-2126(01)00654-2 · doi:10.1016/s0969-2126(01)00654-2
  16. Puchi, 2006, Microinjection of an antibody against the cysteine-protease involved in male chromatin remodeling blocks the development of sea urchin embryos at the initial cell cycle, J. Cell Biochem., 98, 335, 10.1002/jcb.20800 · doi:10.1002/jcb.20800
  17. Petersen, 2001, Localization of epitopes for monoclonal antibodies to urokinase-type plasminogen activator: relationship between epitope localization and effects of antibodies on molecular interactions of the enzyme, Eur. J. Biochem., 268, 4430, 10.1046/j.1432-1327.2001.02365.x · doi:10.1046/j.1432-1327.2001.02365.x
  18. Matias-Roman, 2005, Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium, Blood, 105, 3956, 10.1182/blood-2004-06-2382 · DOI
  19. Xuan, 2006, Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture, Cancer Res., 66, 3611, 10.1158/0008-5472.CAN-05-2983 · doi:10.1158/0008-5472.can-05-2983
  20. Obermajer, 2006, Carboxypeptidase cathepsin X mediates beta2-integrin-dependent adhesion of differentiated U-937 cells, Expt. Cell Res., 312, 2515, 10.1016/j.yexcr.2006.04.019 · DOI
  21. Maun, 2003, Engineering exosite peptides for complete inhibition of factor VIIa using a protease switch with substrate phage, J. Biol. Chem., 278, 21823, 10.1074/jbc.M300951200 · doi:10.1074/jbc.m300951200
  22. Sun, 2003, Potent and selective inhibition of membrane-type serine protease 1 by human single-chain antibodies, Biochemistry, 42, 892, 10.1021/bi026878f · doi:10.1021/bi026878f
  23. Takeuchi, 1999, Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue, Proc. Natl Acad. Sci. USA, 96, 11054, 10.1073/pnas.96.20.11054 · doi:10.1073/pnas.96.20.11054
  24. Lin, 1999, Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk, J. Biol. Chem., 274, 18237, 10.1074/jbc.274.26.18237 · doi:10.1074/jbc.274.26.18237
  25. Uhland, 2006, Matriptase and its putative role in cancer, Cell Mol. Life Sci., 63, 2968, 10.1007/s00018-006-6298-x · DOI · Paper page
  26. List, 2005, Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation, Genes Dev., 19, 1934, 10.1101/gad.1300705 · DOI · Paper page
  27. Knappik, 2000, Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides, J. Mol. Biol., 296, 57, 10.1006/jmbi.1999.3444 · DOI · Paper page
  28. Morrison, 1988, The behavior and significance of slow-binding enzyme inhibitors, Advan. Enzymol. Relat. Areas Mol. Biol., 61, 201
  29. Williams, 1979, The kinetics of reversible tight-binding inhibition, Methods Enzymol., 63, 437, 10.1016/0076-6879(79)63019-7 · DOI · Paper page
  30. Evans, 1982, p-Aminobenzamidine as a fluorescent probe for the active site of serine proteases, J. Biol. Chem., 257, 3014, 10.1016/S0021-9258(19)81066-9 · doi:10.1016/s0021-9258(19)81066-9
  31. Parry, 1994, Kinetic mechanism for the interaction of Hirulog with thrombin, Biochemistry, 33, 14807, 10.1021/bi00253a020 · doi:10.1021/bi00253a020
  32. Fernandez, 1999, Draculin, the anticoagulant factor in vampire bat saliva, is a tight-binding, noncompetitive inhibitor of activated factor X, Biochim. Biophys. Acta, 1434, 135, 10.1016/S0167-4838(99)00160-0 · doi:10.1016/s0167-4838(99)00160-0
  33. Ozawa, 1966, The reactive site of trypsin inhibitors, J. Biol. Chem., 241, 3955, 10.1016/S0021-9258(18)99798-X · doi:10.1016/s0021-9258(18)99798-x
  34. McGrath, 1991, The sequence and reactive site of ecotin. A general inhibitor of pancreatic serine proteases from Escherichia coli, J. Biol. Chem., 266, 6620, 10.1016/S0021-9258(18)38162-6 · DOI
  35. Cunningham, 1989, High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis, Science, 244, 1081, 10.1126/science.2471267 · DOI · Paper page
  36. Friedrich, 2002, Catalytic domain structures of MT-SP1/matriptase, a matrix-degrading transmembrane serine proteinase, J. Biol. Chem., 277, 2160, 10.1074/jbc.M109830200 · doi:10.1074/jbc.m109830200
  37. Luthy, 1973, Detailed mechanism of interaction of bovine-trypsin with soybean trypsin inhibitor (Kunitz). I. Stopped flow measurements, J. Biol. Chem., 248, 1760, 10.1016/S0021-9258(19)44256-7 · doi:10.1016/s0021-9258(19)44256-7
  38. Schreiber, 1996, Rapid, electrostatically assisted association of proteins, Nature Struct. Biol., 3, 427, 10.1038/nsb0596-427 · DOI · Paper page
  39. Rezaie, 2004, Kinetics of factor Xa inhibition by recombinant tick anticoagulant peptide: both active site and exosite interactions are required for a slow- and tight-binding inhibition mechanism, Biochemistry, 43, 3368, 10.1021/bi036177y · doi:10.1021/bi036177y
  40. Martin, 1997, Affinity selection of a camelized V(H) domain antibody inhibitor of hepatitis C virus NS3 protease, Protein Eng., 10, 607, 10.1093/protein/10.5.607 · DOI
  41. Bhatt, 2007, Coordinate expression and functional profiling identify and extracellular proteolytic signaling pathway, Proc. Natl Acad. Sci. USA, 104, 5771, 10.1073/pnas.0606514104 · doi:10.1073/pnas.0606514104
  42. Jameson, 1973, Determination of the operational molarity of solutions of bovine alpha-chymotrypsin, trypsin, thrombin and factor Xa by spectrofluorimetric titration, Biochem. J., 131, 107, 10.1042/bj1310107 · DOI · Paper page
  43. Chou, 1974, Relationships between inhibition constants and fractional inhibition in enzyme-catalyzed reactions with different numbers of reactants, different reaction mechanisms, and different types and mechanisms of inhibition, Mol. Pharmacol., 10, 235

Cited by

See all 50

Metadata

Authors
Farady, C. J., Sun, J., Darragh, M. R., Miller, S. M., & Craik, C. S.
Venue
Journal of Molecular Biology
Publisher
Elsevier BV
Published
2007-06
Volume
369
Issue
4
Pages
1041-1051
ISSN
0022-2836
Cited by
50
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Mechanism of Inhibition of Antibody-based Inhibitors of Membrane-type Serine Protease 1 (MT-SP1). https://app.cochat.ai/papers/10.1016/j.jmb.2007.03.078
The paper
Farady, C. J., Sun, J., Darragh, M. R., Miller, S. M., & Craik, C. S. (2007). The Mechanism of Inhibition of Antibody-based Inhibitors of Membrane-type Serine Protease 1 (MT-SP1). Journal of Molecular Biology. https://doi.org/10.1016/j.jmb.2007.03.078

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.